Sunshine Biopharma (SBFM) Interest Coverage Ratio (2012 - 2024)
Sunshine Biopharma's (SBFM) quarterly Interest Coverage Ratio came in at 238.92 in Q4 2024, down 505.93% on a YoY basis from 58.86 in Q1 2024, and up 95.38% quarter-over-quarter from 5176.64 in Q2 2024.
Powered by 
Analysis
Sunshine Biopharma (SBFM) Interest Coverage Ratio (2012 - 2024) Analysis & Trends
Sunshine Biopharma (SBFM) has reported Interest Coverage Ratio for 12 consecutive years, with 238.92 the latest figure, recorded in Q4 2024.
- For the quarter ending Q4 2024, Interest Coverage Ratio fell 505.93% year-over-year to 238.92; the trailing twelve-month figure through Sep 2025 stood at 759.14 (down 1129.11% YoY), and the FY2024 full-year result was 662.43, down 1800.74% from the prior year.
- Interest Coverage Ratio advanced to 238.92 in Q4 2024 per SBFM's latest filing, from 5176.64 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 1.99 in Q2 2021 and bottomed at 858990.0 in Q3 2022.
- Historically, Interest Coverage Ratio has averaged 48104.26 across 5 years, with a median of 26.56 in 2024.
- The sharpest annual moves came in 2022 and 2023: Interest Coverage Ratio slumped 8109137.82% in 2022, then soared 100.0% in 2023.
- Over 5 years, Interest Coverage Ratio stood at 3.26 in 2020, then plunged by 134.44% to 7.63 in 2021, then sank by 11429.02% to 880.12 in 2022, then soared by 95.52% to 39.43 in 2023, then plunged by 505.93% to 238.92 in 2024.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 238.92, 5176.64, and 27.46 for Q4 2024, Q2 2024, and Q1 2024 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | 0.05 |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 3.02 |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 1.87 |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -1.79 |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 5.97 |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | 579.00 |
| 10 | Sunshine Biopharma | 1.55 Mn | -12.20 Mn | 2.43 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -238.92 |
| Jun 30, 2024 | -5,176.64 |
| Mar 31, 2024 | -27.46 |
| Dec 31, 2023 | -39.43 |
| Sep 30, 2023 | -20.23 |
| Jun 30, 2023 | -304.38 |
| Mar 31, 2023 | -44.53 |
| Dec 31, 2022 | -880.12 |
| Sep 30, 2022 | -858,990.00 |
| Mar 31, 2022 | -95.10 |
| Dec 31, 2021 | -7.63 |
| Sep 30, 2021 | -10.59 |
| Jun 30, 2021 | -1.99 |
| Mar 31, 2021 | -25.66 |
| Dec 31, 2020 | -3.26 |
| Sep 30, 2020 | -3.05 |
| Jun 30, 2020 | -5.31 |
| Mar 31, 2020 | -2.30 |
| Dec 31, 2019 | -10.70 |
| Sep 30, 2019 | -7.28 |